Global Rare Disease Genetic Testing Market Growth (Status and Outlook) 2023-2029

February 2023 | 110 pages | ID: GF64C5A22E24EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Rare Disease Genetic Testing Industry Forecast” looks at past sales and reviews total world Rare Disease Genetic Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Rare Disease Genetic Testing sales for 2023 through 2029. With Rare Disease Genetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rare Disease Genetic Testing industry.

This Insight Report provides a comprehensive analysis of the global Rare Disease Genetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rare Disease Genetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rare Disease Genetic Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rare Disease Genetic Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rare Disease Genetic Testing.

The global Rare Disease Genetic Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Rare Disease Genetic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Rare Disease Genetic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Rare Disease Genetic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Rare Disease Genetic Testing players cover Quest Diagnostics, Centogene, Invitae Corporation, 3billion, Arup Laboratories, Eurofins Scientific, Strand Life Sciences, Ambry Genetics and Perkin Elmer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Rare Disease Genetic Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Next-Generation Sequencing (NGS)
• Array Technology
• PCR-based Testing
• Fluorescence in Situ Hybridization (FISH)
• Sanger Sequencing
• Karyotyping
• Others

Segmentation by application

• Research Laboratories and CROs
• Diagnostic Laboratories
• Hospitals and Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Quest Diagnostics
• Centogene
• Invitae Corporation
• 3billion
• Arup Laboratories
• Eurofins Scientific
• Strand Life Sciences
• Ambry Genetics
• Perkin Elmer
• Macrogen
• Baylor Genetics
• Color Genomics
• Preventiongenetics
• Progenity
• Coopersurgical
• Fulgent Genetics
• Myriad Genetics
• LabCorp
• Opko Health

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rare Disease Genetic Testing Market Size 2018-2029
  2.1.2 Rare Disease Genetic Testing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Rare Disease Genetic Testing Segment by Type
  2.2.1 Next-Generation Sequencing (NGS)
  2.2.2 Array Technology
  2.2.3 PCR-based Testing
  2.2.4 Fluorescence in Situ Hybridization (FISH)
  2.2.5 Sanger Sequencing
  2.2.6 Karyotyping
  2.2.7 Others
2.3 Rare Disease Genetic Testing Market Size by Type
  2.3.1 Rare Disease Genetic Testing Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Rare Disease Genetic Testing Market Size Market Share by Type (2018-2023)
2.4 Rare Disease Genetic Testing Segment by Application
  2.4.1 Research Laboratories and CROs
  2.4.2 Diagnostic Laboratories
  2.4.3 Hospitals and Clinics
  2.4.4 Others
2.5 Rare Disease Genetic Testing Market Size by Application
  2.5.1 Rare Disease Genetic Testing Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Rare Disease Genetic Testing Market Size Market Share by Application (2018-2023)

3 RARE DISEASE GENETIC TESTING MARKET SIZE BY PLAYER

3.1 Rare Disease Genetic Testing Market Size Market Share by Players
  3.1.1 Global Rare Disease Genetic Testing Revenue by Players (2018-2023)
  3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Rare Disease Genetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RARE DISEASE GENETIC TESTING BY REGIONS

4.1 Rare Disease Genetic Testing Market Size by Regions (2018-2023)
4.2 Americas Rare Disease Genetic Testing Market Size Growth (2018-2023)
4.3 APAC Rare Disease Genetic Testing Market Size Growth (2018-2023)
4.4 Europe Rare Disease Genetic Testing Market Size Growth (2018-2023)
4.5 Middle East & Africa Rare Disease Genetic Testing Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Rare Disease Genetic Testing Market Size by Country (2018-2023)
5.2 Americas Rare Disease Genetic Testing Market Size by Type (2018-2023)
5.3 Americas Rare Disease Genetic Testing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rare Disease Genetic Testing Market Size by Region (2018-2023)
6.2 APAC Rare Disease Genetic Testing Market Size by Type (2018-2023)
6.3 APAC Rare Disease Genetic Testing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Rare Disease Genetic Testing by Country (2018-2023)
7.2 Europe Rare Disease Genetic Testing Market Size by Type (2018-2023)
7.3 Europe Rare Disease Genetic Testing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rare Disease Genetic Testing by Region (2018-2023)
8.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2018-2023)
8.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RARE DISEASE GENETIC TESTING MARKET FORECAST

10.1 Global Rare Disease Genetic Testing Forecast by Regions (2024-2029)
  10.1.1 Global Rare Disease Genetic Testing Forecast by Regions (2024-2029)
  10.1.2 Americas Rare Disease Genetic Testing Forecast
  10.1.3 APAC Rare Disease Genetic Testing Forecast
  10.1.4 Europe Rare Disease Genetic Testing Forecast
  10.1.5 Middle East & Africa Rare Disease Genetic Testing Forecast
10.2 Americas Rare Disease Genetic Testing Forecast by Country (2024-2029)
  10.2.1 United States Rare Disease Genetic Testing Market Forecast
  10.2.2 Canada Rare Disease Genetic Testing Market Forecast
  10.2.3 Mexico Rare Disease Genetic Testing Market Forecast
  10.2.4 Brazil Rare Disease Genetic Testing Market Forecast
10.3 APAC Rare Disease Genetic Testing Forecast by Region (2024-2029)
  10.3.1 China Rare Disease Genetic Testing Market Forecast
  10.3.2 Japan Rare Disease Genetic Testing Market Forecast
  10.3.3 Korea Rare Disease Genetic Testing Market Forecast
  10.3.4 Southeast Asia Rare Disease Genetic Testing Market Forecast
  10.3.5 India Rare Disease Genetic Testing Market Forecast
  10.3.6 Australia Rare Disease Genetic Testing Market Forecast
10.4 Europe Rare Disease Genetic Testing Forecast by Country (2024-2029)
  10.4.1 Germany Rare Disease Genetic Testing Market Forecast
  10.4.2 France Rare Disease Genetic Testing Market Forecast
  10.4.3 UK Rare Disease Genetic Testing Market Forecast
  10.4.4 Italy Rare Disease Genetic Testing Market Forecast
  10.4.5 Russia Rare Disease Genetic Testing Market Forecast
10.5 Middle East & Africa Rare Disease Genetic Testing Forecast by Region (2024-2029)
  10.5.1 Egypt Rare Disease Genetic Testing Market Forecast
  10.5.2 South Africa Rare Disease Genetic Testing Market Forecast
  10.5.3 Israel Rare Disease Genetic Testing Market Forecast
  10.5.4 Turkey Rare Disease Genetic Testing Market Forecast
  10.5.5 GCC Countries Rare Disease Genetic Testing Market Forecast
10.6 Global Rare Disease Genetic Testing Forecast by Type (2024-2029)
10.7 Global Rare Disease Genetic Testing Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Quest Diagnostics
  11.1.1 Quest Diagnostics Company Information
  11.1.2 Quest Diagnostics Rare Disease Genetic Testing Product Offered
  11.1.3 Quest Diagnostics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Quest Diagnostics Main Business Overview
  11.1.5 Quest Diagnostics Latest Developments
11.2 Centogene
  11.2.1 Centogene Company Information
  11.2.2 Centogene Rare Disease Genetic Testing Product Offered
  11.2.3 Centogene Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Centogene Main Business Overview
  11.2.5 Centogene Latest Developments
11.3 Invitae Corporation
  11.3.1 Invitae Corporation Company Information
  11.3.2 Invitae Corporation Rare Disease Genetic Testing Product Offered
  11.3.3 Invitae Corporation Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Invitae Corporation Main Business Overview
  11.3.5 Invitae Corporation Latest Developments
11.4 3billion
  11.4.1 3billion Company Information
  11.4.2 3billion Rare Disease Genetic Testing Product Offered
  11.4.3 3billion Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 3billion Main Business Overview
  11.4.5 3billion Latest Developments
11.5 Arup Laboratories
  11.5.1 Arup Laboratories Company Information
  11.5.2 Arup Laboratories Rare Disease Genetic Testing Product Offered
  11.5.3 Arup Laboratories Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Arup Laboratories Main Business Overview
  11.5.5 Arup Laboratories Latest Developments
11.6 Eurofins Scientific
  11.6.1 Eurofins Scientific Company Information
  11.6.2 Eurofins Scientific Rare Disease Genetic Testing Product Offered
  11.6.3 Eurofins Scientific Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Eurofins Scientific Main Business Overview
  11.6.5 Eurofins Scientific Latest Developments
11.7 Strand Life Sciences
  11.7.1 Strand Life Sciences Company Information
  11.7.2 Strand Life Sciences Rare Disease Genetic Testing Product Offered
  11.7.3 Strand Life Sciences Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Strand Life Sciences Main Business Overview
  11.7.5 Strand Life Sciences Latest Developments
11.8 Ambry Genetics
  11.8.1 Ambry Genetics Company Information
  11.8.2 Ambry Genetics Rare Disease Genetic Testing Product Offered
  11.8.3 Ambry Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Ambry Genetics Main Business Overview
  11.8.5 Ambry Genetics Latest Developments
11.9 Perkin Elmer
  11.9.1 Perkin Elmer Company Information
  11.9.2 Perkin Elmer Rare Disease Genetic Testing Product Offered
  11.9.3 Perkin Elmer Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Perkin Elmer Main Business Overview
  11.9.5 Perkin Elmer Latest Developments
11.10 Macrogen
  11.10.1 Macrogen Company Information
  11.10.2 Macrogen Rare Disease Genetic Testing Product Offered
  11.10.3 Macrogen Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Macrogen Main Business Overview
  11.10.5 Macrogen Latest Developments
11.11 Baylor Genetics
  11.11.1 Baylor Genetics Company Information
  11.11.2 Baylor Genetics Rare Disease Genetic Testing Product Offered
  11.11.3 Baylor Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Baylor Genetics Main Business Overview
  11.11.5 Baylor Genetics Latest Developments
11.12 Color Genomics
  11.12.1 Color Genomics Company Information
  11.12.2 Color Genomics Rare Disease Genetic Testing Product Offered
  11.12.3 Color Genomics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Color Genomics Main Business Overview
  11.12.5 Color Genomics Latest Developments
11.13 Preventiongenetics
  11.13.1 Preventiongenetics Company Information
  11.13.2 Preventiongenetics Rare Disease Genetic Testing Product Offered
  11.13.3 Preventiongenetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Preventiongenetics Main Business Overview
  11.13.5 Preventiongenetics Latest Developments
11.14 Progenity
  11.14.1 Progenity Company Information
  11.14.2 Progenity Rare Disease Genetic Testing Product Offered
  11.14.3 Progenity Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.14.4 Progenity Main Business Overview
  11.14.5 Progenity Latest Developments
11.15 Coopersurgical
  11.15.1 Coopersurgical Company Information
  11.15.2 Coopersurgical Rare Disease Genetic Testing Product Offered
  11.15.3 Coopersurgical Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.15.4 Coopersurgical Main Business Overview
  11.15.5 Coopersurgical Latest Developments
11.16 Fulgent Genetics
  11.16.1 Fulgent Genetics Company Information
  11.16.2 Fulgent Genetics Rare Disease Genetic Testing Product Offered
  11.16.3 Fulgent Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.16.4 Fulgent Genetics Main Business Overview
  11.16.5 Fulgent Genetics Latest Developments
11.17 Myriad Genetics
  11.17.1 Myriad Genetics Company Information
  11.17.2 Myriad Genetics Rare Disease Genetic Testing Product Offered
  11.17.3 Myriad Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.17.4 Myriad Genetics Main Business Overview
  11.17.5 Myriad Genetics Latest Developments
11.18 LabCorp
  11.18.1 LabCorp Company Information
  11.18.2 LabCorp Rare Disease Genetic Testing Product Offered
  11.18.3 LabCorp Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.18.4 LabCorp Main Business Overview
  11.18.5 LabCorp Latest Developments
11.19 Opko Health
  11.19.1 Opko Health Company Information
  11.19.2 Opko Health Rare Disease Genetic Testing Product Offered
  11.19.3 Opko Health Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.19.4 Opko Health Main Business Overview
  11.19.5 Opko Health Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rare Disease Genetic Testing Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Next-Generation Sequencing (NGS)
Table 3. Major Players of Array Technology
Table 4. Major Players of PCR-based Testing
Table 5. Major Players of Fluorescence in Situ Hybridization (FISH)
Table 6. Major Players of Sanger Sequencing
Table 7. Major Players of Karyotyping
Table 8. Major Players of Others
Table 9. Rare Disease Genetic Testing Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Rare Disease Genetic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Rare Disease Genetic Testing Market Size Market Share by Type (2018-2023)
Table 12. Rare Disease Genetic Testing Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Rare Disease Genetic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Rare Disease Genetic Testing Market Size Market Share by Application (2018-2023)
Table 15. Global Rare Disease Genetic Testing Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Rare Disease Genetic Testing Revenue Market Share by Player (2018-2023)
Table 17. Rare Disease Genetic Testing Key Players Head office and Products Offered
Table 18. Rare Disease Genetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Rare Disease Genetic Testing Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Rare Disease Genetic Testing Market Size Market Share by Regions (2018-2023)
Table 23. Global Rare Disease Genetic Testing Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Rare Disease Genetic Testing Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Rare Disease Genetic Testing Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Rare Disease Genetic Testing Market Size Market Share by Country (2018-2023)
Table 27. Americas Rare Disease Genetic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Rare Disease Genetic Testing Market Size Market Share by Type (2018-2023)
Table 29. Americas Rare Disease Genetic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Rare Disease Genetic Testing Market Size Market Share by Application (2018-2023)
Table 31. APAC Rare Disease Genetic Testing Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Rare Disease Genetic Testing Market Size Market Share by Region (2018-2023)
Table 33. APAC Rare Disease Genetic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Rare Disease Genetic Testing Market Size Market Share by Type (2018-2023)
Table 35. APAC Rare Disease Genetic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Rare Disease Genetic Testing Market Size Market Share by Application (2018-2023)
Table 37. Europe Rare Disease Genetic Testing Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Rare Disease Genetic Testing Market Size Market Share by Country (2018-2023)
Table 39. Europe Rare Disease Genetic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Rare Disease Genetic Testing Market Size Market Share by Type (2018-2023)
Table 41. Europe Rare Disease Genetic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Rare Disease Genetic Testing Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Rare Disease Genetic Testing Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Rare Disease Genetic Testing
Table 50. Key Market Challenges & Risks of Rare Disease Genetic Testing
Table 51. Key Industry Trends of Rare Disease Genetic Testing
Table 52. Global Rare Disease Genetic Testing Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Rare Disease Genetic Testing Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Rare Disease Genetic Testing Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Rare Disease Genetic Testing Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Quest Diagnostics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 57. Quest Diagnostics Rare Disease Genetic Testing Product Offered
Table 58. Quest Diagnostics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Quest Diagnostics Main Business
Table 60. Quest Diagnostics Latest Developments
Table 61. Centogene Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 62. Centogene Rare Disease Genetic Testing Product Offered
Table 63. Centogene Main Business
Table 64. Centogene Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Centogene Latest Developments
Table 66. Invitae Corporation Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 67. Invitae Corporation Rare Disease Genetic Testing Product Offered
Table 68. Invitae Corporation Main Business
Table 69. Invitae Corporation Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Invitae Corporation Latest Developments
Table 71. 3billion Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 72. 3billion Rare Disease Genetic Testing Product Offered
Table 73. 3billion Main Business
Table 74. 3billion Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. 3billion Latest Developments
Table 76. Arup Laboratories Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 77. Arup Laboratories Rare Disease Genetic Testing Product Offered
Table 78. Arup Laboratories Main Business
Table 79. Arup Laboratories Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Arup Laboratories Latest Developments
Table 81. Eurofins Scientific Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 82. Eurofins Scientific Rare Disease Genetic Testing Product Offered
Table 83. Eurofins Scientific Main Business
Table 84. Eurofins Scientific Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Eurofins Scientific Latest Developments
Table 86. Strand Life Sciences Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 87. Strand Life Sciences Rare Disease Genetic Testing Product Offered
Table 88. Strand Life Sciences Main Business
Table 89. Strand Life Sciences Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Strand Life Sciences Latest Developments
Table 91. Ambry Genetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 92. Ambry Genetics Rare Disease Genetic Testing Product Offered
Table 93. Ambry Genetics Main Business
Table 94. Ambry Genetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Ambry Genetics Latest Developments
Table 96. Perkin Elmer Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 97. Perkin Elmer Rare Disease Genetic Testing Product Offered
Table 98. Perkin Elmer Main Business
Table 99. Perkin Elmer Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Perkin Elmer Latest Developments
Table 101. Macrogen Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 102. Macrogen Rare Disease Genetic Testing Product Offered
Table 103. Macrogen Main Business
Table 104. Macrogen Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Macrogen Latest Developments
Table 106. Baylor Genetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 107. Baylor Genetics Rare Disease Genetic Testing Product Offered
Table 108. Baylor Genetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. Baylor Genetics Main Business
Table 110. Baylor Genetics Latest Developments
Table 111. Color Genomics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 112. Color Genomics Rare Disease Genetic Testing Product Offered
Table 113. Color Genomics Main Business
Table 114. Color Genomics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Color Genomics Latest Developments
Table 116. Preventiongenetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 117. Preventiongenetics Rare Disease Genetic Testing Product Offered
Table 118. Preventiongenetics Main Business
Table 119. Preventiongenetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Preventiongenetics Latest Developments
Table 121. Progenity Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 122. Progenity Rare Disease Genetic Testing Product Offered
Table 123. Progenity Main Business
Table 124. Progenity Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Progenity Latest Developments
Table 126. Coopersurgical Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 127. Coopersurgical Rare Disease Genetic Testing Product Offered
Table 128. Coopersurgical Main Business
Table 129. Coopersurgical Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Coopersurgical Latest Developments
Table 131. Fulgent Genetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 132. Fulgent Genetics Rare Disease Genetic Testing Product Offered
Table 133. Fulgent Genetics Main Business
Table 134. Fulgent Genetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Fulgent Genetics Latest Developments
Table 136. Myriad Genetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 137. Myriad Genetics Rare Disease Genetic Testing Product Offered
Table 138. Myriad Genetics Main Business
Table 139. Myriad Genetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Myriad Genetics Latest Developments
Table 141. LabCorp Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 142. LabCorp Rare Disease Genetic Testing Product Offered
Table 143. LabCorp Main Business
Table 144. LabCorp Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. LabCorp Latest Developments
Table 146. Opko Health Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 147. Opko Health Rare Disease Genetic Testing Product Offered
Table 148. Opko Health Main Business
Table 149. Opko Health Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Opko Health Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Rare Disease Genetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rare Disease Genetic Testing Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Rare Disease Genetic Testing Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Rare Disease Genetic Testing Sales Market Share by Country/Region (2022)
Figure 8. Rare Disease Genetic Testing Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Rare Disease Genetic Testing Market Size Market Share by Type in 2022
Figure 10. Rare Disease Genetic Testing in Research Laboratories and CROs
Figure 11. Global Rare Disease Genetic Testing Market: Research Laboratories and CROs (2018-2023) & ($ Millions)
Figure 12. Rare Disease Genetic Testing in Diagnostic Laboratories
Figure 13. Global Rare Disease Genetic Testing Market: Diagnostic Laboratories (2018-2023) & ($ Millions)
Figure 14. Rare Disease Genetic Testing in Hospitals and Clinics
Figure 15. Global Rare Disease Genetic Testing Market: Hospitals and Clinics (2018-2023) & ($ Millions)
Figure 16. Rare Disease Genetic Testing in Others
Figure 17. Global Rare Disease Genetic Testing Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Rare Disease Genetic Testing Market Size Market Share by Application in 2022
Figure 19. Global Rare Disease Genetic Testing Revenue Market Share by Player in 2022
Figure 20. Global Rare Disease Genetic Testing Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Rare Disease Genetic Testing Market Size 2018-2023 ($ Millions)
Figure 22. APAC Rare Disease Genetic Testing Market Size 2018-2023 ($ Millions)
Figure 23. Europe Rare Disease Genetic Testing Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Rare Disease Genetic Testing Market Size 2018-2023 ($ Millions)
Figure 25. Americas Rare Disease Genetic Testing Value Market Share by Country in 2022
Figure 26. United States Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Rare Disease Genetic Testing Market Size Market Share by Region in 2022
Figure 31. APAC Rare Disease Genetic Testing Market Size Market Share by Type in 2022
Figure 32. APAC Rare Disease Genetic Testing Market Size Market Share by Application in 2022
Figure 33. China Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Rare Disease Genetic Testing Market Size Market Share by Country in 2022
Figure 40. Europe Rare Disease Genetic Testing Market Size Market Share by Type (2018-2023)
Figure 41. Europe Rare Disease Genetic Testing Market Size Market Share by Application (2018-2023)
Figure 42. Germany Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Rare Disease Genetic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 56. APAC Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 57. Europe Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 59. United States Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 60. Canada Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 63. China Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 64. Japan Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 65. Korea Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 67. India Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 68. Australia Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 69. Germany Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 70. France Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 71. UK Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 72. Italy Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 73. Russia Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 74. Spain Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 77. Israel Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Rare Disease Genetic Testing Market Size 2024-2029 ($ Millions)
Figure 80. Global Rare Disease Genetic Testing Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Rare Disease Genetic Testing Market Size Market Share Forecast by Application (2024-2029)